Poremećaj spavanja zbog sindroma nemirnih nogu
Sažetak
Uvod/Cilj. Sindrom nemirnih nogu (SNN) je hronična neurološka bolest koju karakteriše potreba za pomeranjem nogu udružena sa neprijatnim senzacijama u donjim ekstremitetima. Poremećaji spavanja spadaju u glavne prateće simptome SNN koji se javljaju kod oko 90% bolesnika. Poremećaji spavanja dovode do dnevne pospanosti, depresivnosti i anksioznosti. Cilj ove studije bio je da detektuje učestalost i karakteristike poremećaja spavanja kod bolesnika sa SNN, kao i njihov uticaj na dnevnu pospanost, umor, anksioznost i depresivnost. Metode. Ispitano je 94 bolesnika sa SNN. Dijagnoza SNN postavljena je na osnovu kriterijuma Internacionalne grupe za proučavanje sindroma nemirnih nogu (International Restless Legs Syndrome Study Group – IRLSSG) iz 2003. godine. Težina kliničke slike procenjena je pomoću IRLSSG roling scale, depresivnost i anksioznost Hamiltonovom skalom za procenu depresivnosti i anksioznosti, a pospanost Epworthovom skalom pospanosti. Posebnim upitnikom ocenjivali smo karakteristike sna i njegove poremećaje. Rezultati. U našoj studiji 79,9% bolesnika imalo je poremećaje spavanja. Prosečna dužina sna bila je 6,50±1,42 sati sa prosečnim buđenjem 2,34 ± 1,69 puta u toku noći. Prosečan skor na Epworthovoj skali pospanosti bio je 5,12 ± 4,08 (0–17). Bolesnici sa većom učestalošću tegoba imali su statistički značajno veći stepen pospanosti (p = 0,005). Bolesnici sa većom učestlošću tegoba imali su češće poremećaje spavanja (p = 0,016), umor i dnevnu pospanost (p = 0,001). Dnevna pospanost značajno je korelirala sa depresivnošću (p < 0,05) i anksioznošću (p = 0,012). Zaključak. Naši rezultati potvrđuju da su poremećaji spavanja ključni prateći simptomi SNN koji uzrokuju dnevnu pospanost, umor, depresivnost i anksioznost. Zato je njihovo rano prepoznavanje i adekvatno lečenje od velikog značaja.
Reference
Reference
Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J. Restless Legs Syndrome Diagnosis and Epidemi-ology workshop at the National Institutes of Health; Interna-tional Restless Legs Syndrome Study Group. Restless legs syn-drome: diagnostic criteria, special considerations, and epide-miology. Areport from the restless legs syndrome diagnosis and epidemiology workshop at theNational Institutes of Health. Sleep Med 2003; 4(2): 101−19.
Ohayon MM, O’hara R, Vitiello MV. Epidemiology of restless legs syndrome: A synthesis of the literature. Sleep Med Rev 2012; 16(4): 283−95.
Pekmezovic T, Jovic J, Svetel M, Kostic VS. Prevalence of restless legs syndrome among adult population in a Serbian district: A community-based study. Eur J Epidemiol 2013; 28(11): 927−30.
Mathis J. Update on restless legs. Swiss Med Wkly 2005; 135(47−48): 687−96.
Earley CJ, Silber MH. Restless legs syndrome: Understanding its consequences and the need for better treatment. Sleep Med 2010; 11(9): 807−15.
Fulda S, Szesny N, Ising M, Heck A, Grübl A, Lieb R, et al. Fur-ther evidence for executive dysfunction in subjects with RLS from a non-clinical sample. Sleep Med 2011; 12(10): 1003−7.
Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56−62.
Hamilton M. A diagnosis and rating of anxiety. Br J Psychiatry 1969; 3: 76−9.
Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991; 14(6): 540−5.
Garcia-Borreguero D. Time to REST: epidemiology and burden. Eur J Neurol 2006; 13(Suppl 3): 15−20.
Allen RP, Walters AS, Montplaisir J, Hening W, Myers A, Bell TJ, et al. Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med 2005; 165(11): 1286−92.
Allen RP, Montplaisir J, Ulfberg J. Restless legs. New insights. Kristianstad, Sweden: Rafael Bokförlag; 2003.
Lasch KE, Abraham L, Patrick J, Piault EC, Tully SE, Treglia M. Development of a next day functioning measure to assess the impact of sleep disturbance due to restless legs syndrome: the restless legs syndrome-next day impact questionnaire. Sleep Med 2011; 12(8): 754−61.
Provini F, Antelmi E, Vignatelli L, Zaniboni A, Naldi G, Calandra-Buonaura G, et al. Increased prevalence of nocturnal smoking in restless legs syndrome (RLS). Sleep Med 2010; 11(2): 218−20.
Fulda S, Wetter TC. Is daytime sleepiness a neglected problem in patients with restless legs syndrome? Mov Disord 2007; 22 Suppl 18: S409−13.
Kim JB, Koo YS, Eun MY, Park KW, Jung KY. Psychosomatic symptom profiles in patients with restless legs syndrome. Sleep Breath 2013; 17(3): 1055−61.
Li Y, Mirzaei F, O’Reilly EJ, Winkelman J, Malhotra A, Okereke OI, et al. Prospective study of restless legs syndrome and risk of depression in women. Am J Epidemiol 2012; 176(4): 279−88.
Innes KE, Selfe TK, Agarwal P. Restless legs syndrome and con-ditions associated with metabolic dysregulation, sym-pathoadrenal dysfunction, and cardiovascular disease risk: A systematic review. Sleep Med Rev 2012; 16(4): 309−39.